Cogent Biosciences, Inc. (COGT)
37.34
-1.00
(-2.61%)
USD |
NASDAQ |
Feb 20, 16:00
37.56
+0.22
(+0.59%)
After-Hours: 20:00
Cogent Biosciences Total Assets (Quarterly) : 937.61M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | -- |
| Sarepta Therapeutics, Inc. | 3.493B |
| Cidara Therapeutics, Inc. | 518.65M |
| BridgeBio Pharma, Inc. | 998.25M |
| Olema Pharmaceuticals, Inc. | 352.45M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 301.24M |
| Shareholders Equity (Quarterly) | 636.37M |
| Debt to Equity Ratio | 0.3752 |
| Current Ratio | 14.23 |
| Net Debt Paydown Yield | -0.81% |